Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4865048
Max Phase: Preclinical
Molecular Formula: C51H82N18O12
Molecular Weight: 1139.33
Molecule Type: Unknown
Associated Items:
ID: ALA4865048
Max Phase: Preclinical
Molecular Formula: C51H82N18O12
Molecular Weight: 1139.33
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C51H82N18O12/c1-29(2)26-38(46(79)64-35(9-6-24-60-49(56)57)44(77)66-37(42(53)75)27-30-11-15-32(70)16-12-30)67-45(78)36(10-7-25-61-50(58)69-51(81)62-22-4-3-21-52)65-47(80)39(28-31-13-17-33(71)18-14-31)68-43(76)34(8-5-23-59-48(54)55)63-40(72)19-20-41(73)74/h11-18,29,34-39,70-71H,3-10,19-28,52H2,1-2H3,(H2,53,75)(H,63,72)(H,64,79)(H,65,80)(H,66,77)(H,67,78)(H,68,76)(H,73,74)(H4,54,55,59)(H4,56,57,60)(H4,58,61,62,69,81)/t34-,35-,36-,37-,38-,39-/m0/s1
Standard InChI Key: DBNCGOHCYSORPG-BGBFCPIGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1139.33 | Molecular Weight (Monoisotopic): 1138.6360 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):